Individual patient approval
Medicines which are not on the List of Approved Medicines (LAM) can be accessed through a Hospital and Health Service (HHS) Individual Patient Approval (IPA) process.
Circumstances where an IPA must be sought include:
- use of a medicine which is not on the LAM, or
- where use of the medicine is not in line with its LAM restriction, or
- where an IPA is a requirement of a medicine’s listing on the LAM.
Management and governance
HHS medicines committees are responsible for managing the IPA process.
Queensland Health Guidance on the IPA process is available:
Management and governance of individual patient approvals (PDF, 311KB)
Medicines accessed through the IPA process may result in the initiating hospital bearing ongoing costs.
Where relevant specialist expertise does not exist in a hospital to support this process, advice should be sought from the Queensland Health Medicines Advisory Committee (QHMAC) or relevant specialists at other Queensland Health institutions.
Current individual patient approvals
- Artesunate (PDF, 57KB)
- Budesonide (PDF, 48KB)
- Rasburicase (PDF, 60KB)
- Recombinant activated factor VII (Eptacog Alfa) (PDF, 89KB)
For more information email Medication Services Queensland, QHMAC-Secretariat@health.qld.gov.au